Alpinetin suppresses proliferation of human hepatoma cells by the activation of MKK7 and elevates sensitization to cis-diammined dichloridoplatium.

Tang, Bo

Alpinetin suppresses proliferation of human hepatoma cells by the activation of MKK7 and elevates sensitization to cis-diammined dichloridoplatium. [electronic resource] - Oncology reports Apr 2012 - 1090-6 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Retracted Publication

1791-2431

10.3892/or.2011.1580 doi


Animals
Antineoplastic Agents, Phytogenic--pharmacology
Antineoplastic Combined Chemotherapy Protocols--pharmacology
Blotting, Western
Carcinoma, Hepatocellular--enzymology
Cell Proliferation--drug effects
Cell Survival--drug effects
Cisplatin--pharmacology
Dose-Response Relationship, Drug
Down-Regulation
Enzyme Activation
Enzyme Activators--pharmacology
Flavanones--pharmacology
Flow Cytometry
G1 Phase Cell Cycle Checkpoints--drug effects
Hep G2 Cells
Humans
Liver Neoplasms--enzymology
MAP Kinase Kinase 7--antagonists & inhibitors
Phosphorylation
Protein Kinase Inhibitors--pharmacology
RNA Interference
RNA, Messenger--metabolism
Rats
Resting Phase, Cell Cycle--drug effects
Reverse Transcriptase Polymerase Chain Reaction
Time Factors
Transfection